Virtus Investment Advisers’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.33M Buy
50,825
+40,123
+375% +$1.02M 0.31% 148
2026
Q1
$268K Buy
10,702
+261
+2% +$6.17K 0.07% 298
2025
Q4
$275K Buy
10,441
+1,755
+20% +$38.3K 0.07% 280
2025
Q3
$148K Buy
8,686
+1,508
+21% +$21.6K 0.04% 376
2025
Q2
$90.1K Sell
7,178
-5,828
-45% -$69.4K 0.03% 377
2025
Q1
$155K Buy
+13,006
New +$177K 0.04% 321
2024
Q4
Sell
-9,819
Closed -$123K 412
2024
Q3
$123K Sell
9,819
-7,181
-42% -$78.2K 0.1% 237
2024
Q2
$145K Sell
17,000
-39,363
-70% -$350K 0.12% 211
2024
Q1
$593K Hold
56,363
0.42% 66
2023
Q4
$586K Buy
+56,363
New +$449K 0.44% 61

Other funds holding ZYME

Virtus Investment Advisers's ZYME Position: Q2 2026 in Review

Virtus Investment Advisers increased its Zymeworks (ZYME) stake by 375% in Q2 2026, buying an estimated $1.02M and bringing the position to 50,825 shares worth $1.33M. The position accounts for 0.31% of the portfolio, ranked #148.

Virtus Investment Advisers first reported a position in ZYME in Q4 2023 and has held it in 10 quarters since. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Virtus Investment Advisers held 50,825 shares of Zymeworks worth $1.33M as of Q2 2026.
  • Virtus Investment Advisers bought 40,123 Zymeworks shares in Q2 2026, an estimated $1.02M.
  • Zymeworks made up 0.31% of Virtus Investment Advisers's portfolio in Q2 2026, its #148 holding.
  • Virtus Investment Advisers first reported a position in Zymeworks in Q4 2023 and has held it in 10 quarters since.
  • 202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.